Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumlesh K Dev

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Idrugs : the Investigational Drugs Journal|April 6, 2006
Using RNAi in the clinicKumlesh K Dev
Irish Journal of Medical Science|July 13, 2017
6th Annual Meeting Frontiers in Neurology 2016Kumlesh K Dev
Current Drug Targets|December 20, 2016
Editorial (Thematic Issue: Common Receptor Signalling in Glial & Immune Cells)Kumlesh K Dev
Irish Journal of Medical Science|May 10, 2016
"5th Annual Meeting Frontiers in Neurology 2015"Kumlesh K Dev
Nature Reviews. Drug Discovery|December 2, 2004
Making protein interactions druggable: targeting PDZ domainsKumlesh K Dev
Current Topics in Medicinal Chemistry|February 3, 2007
PDZ domain protein-protein interactions: a case study with PICK1Kumlesh K Dev
Journal of Cell Science|September 12, 2015
Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signallingCatherine O'Sullivan, Kumlesh K Dev
Biomedicines|May 27, 2023
The Effects of Antipsychotics in Experimental Models of Krabbe DiseaseKapil Sharma, Kumlesh K Dev
Drug Discovery Today. Therapeutic Strategies|April 15, 2020
RNA interference as a therapeutic strategy for treating CNS disordersDaniel Hoyer, Kumlesh K Dev
Drug Discovery Today|August 27, 2013
Drug dealers: $20 trillion of in-licensing paymentsPatrik Frei, Kumlesh K Dev
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Idrugs : the Investigational Drugs Journal|April 6, 2006
Using RNAi in the clinicKumlesh K Dev
Irish Journal of Medical Science|July 13, 2017
6th Annual Meeting Frontiers in Neurology 2016Kumlesh K Dev
Current Drug Targets|December 20, 2016
Editorial (Thematic Issue: Common Receptor Signalling in Glial & Immune Cells)Kumlesh K Dev
Irish Journal of Medical Science|May 10, 2016
"5th Annual Meeting Frontiers in Neurology 2015"Kumlesh K Dev
Nature Reviews. Drug Discovery|December 2, 2004
Making protein interactions druggable: targeting PDZ domainsKumlesh K Dev
Current Topics in Medicinal Chemistry|February 3, 2007
PDZ domain protein-protein interactions: a case study with PICK1Kumlesh K Dev
Journal of Cell Science|September 12, 2015
Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signallingCatherine O'Sullivan, Kumlesh K Dev
Biomedicines|May 27, 2023
The Effects of Antipsychotics in Experimental Models of Krabbe DiseaseKapil Sharma, Kumlesh K Dev
Drug Discovery Today. Therapeutic Strategies|April 15, 2020
RNA interference as a therapeutic strategy for treating CNS disordersDaniel Hoyer, Kumlesh K Dev
Drug Discovery Today|August 27, 2013
Drug dealers: $20 trillion of in-licensing paymentsPatrik Frei, Kumlesh K Dev
Pageof 8